ERINHA offers in‑person and remote access to high containment facilities allowing researchers to advance research on high-consequence pathogens.
ERINHA works to increase our understanding of highly infectious diseases, develop new countermeasures (e.g. vaccines, therapeutics) and diagnostic capabilities, and translate them to the market.
ERINHA is currently looking to expand innovation within high containment research and is searching for exciting projects that require the use of BSL4 laboratory and complementary facilities. These projects may come from researchers who have a drug, vaccine or therapeutic with theoretical efficacy against a highly pathogenic agent.
ERINHA’s senior scientists and experts in biosafety and biosecurity with long-standing experience in operating and maintaining biocontainment facilities (BSL4 and complementary) provide expertise on: